Why It's Not FDA-Approved First and foremost, BPC-157 is not approved by the U.S
Older adults are more likely to be on multiple medications, increasing the potential for interactions
In certain instances, when an auris formulation or composition is administered via intratympanic injection, a reduced frequency of administration alleviates discomfort caused by multiple intratympanic injections in individuals undergoing treatment for a middle and/or inner ear disease, disorder or condition
NAD+ precursors are studied for supplying metabolic substrates
Delivery method dramatically affects how much peptide actually gets where it needs to go
In a placebo-controlled, double-blinded, randomized clinical trial, oral copper supplementation (8 mg/day) in 68 AD patients had a beneficial effect on relevant AD biochemical markers